To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy.
By clicking on the Accept & Close button, you provide your explicit consent to the processing of your data to achieve the above goal.
You can withdraw your consent using the method specified in the Privacy Policy.
Accept & Close
Sputnik International
Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead boosted by taxpayers
It was the end of April just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths when White House adviser Dr. Anthony Fauci announced highly significant news about a drug called remdesivir.
That was surprising because the antiviral drug, owned by Gilead Sciences and developed with investment from the federal government, had languished for years with no apparent commercial use. It had struck out as a treatment for hepatitis C and Ebola.
But early in 2020, when the first global cases of a new pneumonia-like viral illness emerged in China, Gilead resurfaced the compound, branded as Veklury, and shared it with scientists across the globe. From the Oval Office, Fauci, director of the National Institute of Allergy and Infectious Diseases, said remdesivir would be the standard of care for treating coronavirus disease.
COVID-19 drug remdesivir has been a big win for Gilead - with a boost from taxpayers
Sarah Jane Tribble
FacebookTwitterEmail
1of4
Remdesivir, owned by Gilead Sciences of Foster City, was developed with investment from the federal government.Nick Otto / Special to The Chronicle 2020Show MoreShow Less
2of4
California Attorney General Xavier Becerra, whom President Biden has named as his pick to run the Department of Health and Human Services, has looked into remdesivir pricing.Rich Pedroncelli / Associated Press 2019Show MoreShow Less
3of4
Dr. Rochelle Walensky became director of the Centers for Disease Control and Prevention on Monday. She has looked into the pricing of remdesivir.Susan Walsh/Associated PressShow MoreShow Less
Employment Law Firm Outten & Golden Announces Promotion of Five Lawyers in New York City and Washington, DC Offices
Cassandra W. Lenning, Christopher M. McNerney, Amy F. Shulman, Daniel S. Stromberg, and Chauniqua D. Young elected to partnership effective January 1, 2021
News provided by
Share this article
Share this article
NEW YORK, Jan. 27, 2021 /PRNewswire/ Employment law firm Outten & Golden LLP announced today the promotion of Cassandra W. Lenning, Christopher M. McNerney, Amy F. Shulman, Daniel S. Stromberg, and Chauniqua D. Young to partnership effective January 1, 2021.
Outten & Golden LLP
Cassandra W. Lenning is part of the Firm s individual practice group where she represents employees and executives in litigation, arbitration, and negotiation matters. Her practice focuses on claims of discrimination, retaliation, equal pay, and breach of contract, as well as representing individuals sued by their employers for alleged violations of restrictive covenants. She
Michael Rudell, Prominent Entertainment Lawyer, Dies at 77
Natalie Oganesyan, provided by
FacebookTwitterEmail
Michael I. Rudell, a prominent entertainment industry attorney who represented high-profile clients such as novelists Dan Brown and John Grisham, and radio station WGBH, died on Monday in New York City. He was 77.
Rudell, whose career spanned more than five decades, was involved in all aspects of entertainment law, from film to television to executive employment deals to production work to representation of numerous well-known authors in their book publishing, film and television deals.
More from Variety
In addition to practicing law, Rudell wrote a monthly entertainment law column in the New York Law Journal for more than 40 years, lectured extensively and was the chairman of the American Bar Association’s entertainment committee, eventually receiving its Edward Rubin Service Award. He also gave a portion of his time to the Chautauqua Institution, a nonprofit educa